MyFinsight
Home
Blog
About
Proceeds from exercise of
stock options
$31K
Net cash provided by
financing activities
$13K
Canceled cashflow
$18K
Net increase in cash
and cash...
-$15,759K
Canceled cashflow
$13K
Stock-based compensation
$2,085K
Payroll-related accruals
$841K
Accounts payable
$764K
Other current
liabilities
$733K
Depreciation expense
$342K
Prepaid expenses and
other current assets
-$109K
Non-cash lease expense
$62K
Interest receivable
-$58K
Other non-current
assets
-$30K
Lease liability
$26K
Redemptions of short-term
investments
$7,999K
Payments for deferred
initial public offering...
$18K
Net cash used in
operating activities
-$14,839K
Net cash used in
investing activities
-$933K
Canceled cashflow
$5,050K
Canceled cashflow
$7,999K
Net loss
-$19,864K
Purchases of short-term
investments
$7,000K
Other receivables
$25K
Property and equipment
$1,932K
Back
Back
Cash Flow
SpyGlass Pharma, Inc. (SGP)
SpyGlass Pharma, Inc. (SGP)
source: myfinsight.com